Active Shortage

APO-FELODIPINE

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-FELODIPINE in Canada?

Yes. APO-FELODIPINE 5MG has an active shortage reported to Health Canada (last updated May 14, 2026).

Why is APO-FELODIPINE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-FELODIPINE be available again?

The estimated resolution date (May 15, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products

Affected strength5MG

Last updated2026-05-14

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

RENEDIL SRT 5MG

HOECHST ROUSSEL CANADA INC.

5MG · DIN 01989618

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

RENEDIL

SANOFI-AVENTIS CANADA INC

5MG · DIN 02221993

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

SANDOZ FELODIPINE

SANDOZ CANADA INCORPORATED

5MG · DIN 02280264

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

PLENDIL

GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE

2.5MG · DIN 02057778

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

RENEDIL SRT 2.5MG

HOECHST CANADA INC.

2.5MG · DIN 02057786

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

RENEDIL SRT 10MG

HOECHST CANADA INC.

10MG · DIN 00864021

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-05-15

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02452375

Strength

5MG

Dosage Form

TABLET (EXTENDED-RELEASE)

Route

ORAL

Active Ingredient

FELODIPINE

Tier

Unrated

Last Updated

2026-05-14

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-FELODIPINE has 3 shortage/discontinuation reports on file — this is one of them.

2026-09-25

Active Shortage

Disruption of the manufacture of the drug.

2026-08-14

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244